Jill M. Quigley, Director at Terns Pharmaceuticals, Inc. (TERN), sold 24,520 shares at $18.00 ($441K) on 2025-11-04, disclosed to the SEC on 2025-11-05.
Scheduled sale ($441k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| TERN | SELL | 2024-08-05 | $180K | — | Filing → |
| TERN | SELL | 2024-07-17 | $148K | — | Filing → |
| PASG | SELL | 2021-01-22 | $39K | — | Filing → |